Chulalongkorn University, Thailand, and Nagoya University, Japan, in their collaboration to develop an immunotherapy method for curing cancer, reported on the progress of CAR T-cell immunotherapy innovation for treating cancer in leukaemia and B-cell lymphoma patients, which can increase survival rates and reduce cancer recurrence.

Patients with severe Covid-19 and those at risk of getting that eyed for immune treatment